GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Volpara Health Technologies Ltd (ASX:VHT) » Definitions » Intrinsic Value: Projected FCF

Volpara Health Technologies (ASX:VHT) Intrinsic Value: Projected FCF : A$0.00 (As of Jun. 04, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Volpara Health Technologies Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-04), Volpara Health Technologies's Intrinsic Value: Projected FCF is A$0.00. The stock price of Volpara Health Technologies is A$1.145. Therefore, Volpara Health Technologies's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Volpara Health Technologies's Intrinsic Value: Projected FCF or its related term are showing as below:

ASX:VHT's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.26
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Volpara Health Technologies Intrinsic Value: Projected FCF Historical Data

The historical data trend for Volpara Health Technologies's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Volpara Health Technologies Intrinsic Value: Projected FCF Chart

Volpara Health Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - - -

Volpara Health Technologies Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Volpara Health Technologies's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, Volpara Health Technologies's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Volpara Health Technologies's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Volpara Health Technologies's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Volpara Health Technologies's Price-to-Projected-FCF falls into.



Volpara Health Technologies Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Volpara Health Technologies  (ASX:VHT) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Volpara Health Technologies's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=1.145/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Volpara Health Technologies Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Volpara Health Technologies's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Volpara Health Technologies (ASX:VHT) Business Description

Traded in Other Exchanges
Address
40 Mercer Street, Level 14–15, Wellington Central, Wellington, NZL, 6011
Volpara Health Technologies Ltd is a New Zealand-based research, development, and manufacturing company. The business of the company operates through three product categories that include Capital Sales, Software Maintenance Agreements, and Software as a Service. It offers a breast imaging analytics platform that delivers real-time quality assurance and performance monitoring. It operates through the sale of a single suite of medical device software products.

Volpara Health Technologies (ASX:VHT) Headlines

From GuruFocus

Allied Investment Advisors, LLC Goes on Buying Spree in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-13-2022

AMI INVESTMENT MANAGEMENT INC Buys 3, Sells 2 in 1st Quarter

By GuruFocus Research GuruFocus Editor 05-19-2023